Oculis Holding AG (OCS)
31.37
+0.96
(+3.16%)
USD |
NASDAQ |
May 13, 16:00
31.34
-0.04
(-0.11%)
Pre-Market: 20:00
Oculis Shareholders Equity (Quarterly) : 244.72M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 38.51B |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 6.010M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 303.64M |
| Total Liabilities (Quarterly) | 58.92M |
| Debt to Equity Ratio | 0.0114 |
| Current Ratio | 5.176 |
| Net Debt Paydown Yield | -0.02% |